Hong Kong Hotel and Resort REITs Stock News

China Qinfa Group walked into this earnings day with the stock already on a tear, up roughly 42% over the past month, and the latest H1 2026 numbers gave traders another jolt of emotion. The headline is simple. Profitability looked solid on the surface, with basic earnings per share of ¥0.0867 and net income from ongoing operations in the trailing 12 months of ¥378.386m, yet the trailing net margin has eased to 12% while the stock still trades on a P/E of 22.4x. That clash between cooling...

Innovent Biologics heads into this earnings reaction with the stock already up sharply over the past quarter, yet the real story is in how much profit the business is now producing. The headline from H1 2026 is simple: revenue reached C¥8,617.8m and net income excluding extra items came in at C¥1,253.1m, which feeds into a P/E of 133x at around HK$109.8 a share. For you as an investor, the key question is whether today’s price move reflects that profit power or whether sentiment is being...

CIMC Enric Holdings closed at HK$7.65 today after a weak few months for the stock, yet the latest half year numbers tell a more complex story. Earnings per share for H1 2026 came in at ¥0.246 and net income excluding extra items reached ¥516.53m, while the trailing P/E of 12.7x sits just above the Hong Kong machinery average and below the peer group. The bigger question now is not today’s share price flicker; it is whether current margins and projected earnings growth justify the wide gap to...

Greentown China Holdings stock has been grinding higher in recent weeks, yet the latest H1 2026 earnings remind investors why the shares still trade at what looks like a distressed valuation. The company remains loss making on a trailing twelve month basis, even as it reports earnings from continuing operations of ¥1.16b. That disconnect sits next to a P/S ratio of about 0.1x and a market price that is far below one stated fair value estimate. For a heavily leveraged developer, that kind of...

Anton Oilfield Services Group stock closed at HK$0.73 on Wednesday after a rough few months, with the share price down 5.2% over the past week and 27.7% over three months. The market appears to be firmly focused on the squeeze in profitability rather than the headline revenue line. The key story in this half year is margin and earnings pressure. Net income from continuing operations over the trailing twelve months sits at ¥325.0m on revenue of ¥5.6b, which leaves a net profit margin of 5.6%...

Haidilao International Holding stock closed at HK$12.25 on Wednesday, roughly flat over the past week and month, even as the latest results put the focus squarely on profitability pressure. The headline is margin squeeze. Trailing net profit margin now sits at 9%, compared with 10.6% a year earlier, despite higher trailing twelve month revenue of ¥44.86b and earnings from continuing operations of ¥4.05b. Investors who bought into Haidilao for dependable earnings quality now have to weigh a...

Health and Happiness International Holdings came into this week with strong momentum after a 46.7% 90 day run, yet the real story sits in the earnings line rather than the chart. H1 2026 net income reached ¥610.6m with basic earnings per share of ¥0.95, which marks a very different company to the one investors were pricing a year ago. For a consumer health stock long treated as a balance sheet worry, the headline this time is clear. The earnings engine is back in focus and the market now has...

Flat Glass Group stock closed at HK$6.875 on Wednesday, leaving investors to weigh a weak quarter against a more positive long-term view. The headline is simple: Q2 flipped back into the red, with a loss of CN¥401.2m and basic earnings per share of a CN¥0.15 loss, after a small profit in Q1. Yet over the past twelve months the company still reports profit and trades on a P/E of 37.1x, with analysts expecting strong multi year earnings and revenue growth. The tension between that profit...

The market has been cool on C-MER Medical Holdings, with the stock down about 19% over the past three months and closing today at HK$0.845. Yet the latest half year numbers tell a different story. The company stayed profitable in H1 2026, with basic earnings per share of HK$0.0421 on revenue of HK$1,024.4m, and now carries a trailing P/E of 10x compared with higher industry and peer averages. The headline is simple: profitability has taken root while the valuation still prices C-MER Medical...

WuXi Biologics (Cayman) walked into today’s session with the stock already up strongly over the past month and quarter, priced as a high growth contract development and manufacturing story. The headline from this earnings print is simple. Revenue for H1 2026 reached C¥11,787.24m, while basic earnings per share came in at C¥0.60 and the trailing net profit margin held a little above 21%. For a market that has been bidding the stock higher, the key question now is whether that margin profile...

Greentown Management Holdings stock has barely moved over the past month, yet the latest half year numbers tell a more charged story. Earnings have done the heavy lifting. Basic earnings per share for H1 2026 came in at ¥0.14, backed by net income of ¥271.3m on revenue of ¥1.47b. At HK$1.83 a share and on a P/E of 7.2x, which sits well below the Hong Kong construction sector average, the market still prices Greentown Management as if its profit squeeze and cash flow questions matter more than...

China Modern Dairy Holdings stock closed at HK$1.485 on Wednesday, with the market still pricing in a recovery story after a strong 90 day run. The headline from these H1 2026 results is simple: the company has moved from deep losses to a slim profit. Net income from continuing operations improved to a modest gain of ¥18.7m on revenue of ¥6,592.8m. That shift is small in absolute terms but significant for the long term debate around this dairy producer. The question now is whether this first...

The market has been slowly rewarding Jiangxi Copper in recent months. Today’s Q2 print, however, gives a much punchier story than the modest 30 day gain of about 13% might suggest. The stock closed at HK$39.9 just as the company posted quarterly net income of C¥5,814.3m and basic earnings per share of C¥1.68. The headline is simple: profitability did the heavy lifting this quarter, while the valuation case, with a P/E of 10.2x against an industry level of 13.6x, gives bulls more to argue with...

China Merchants Commercial Real Estate Investment Trust came into these results as a beaten up REIT, with the unit price at HK$1.04 and 90 day performance in decline. The long term pitch has often been about value and income; yet the latest half year numbers underline a very different reality. Revenue for H1 2026 sits at ¥191.657 million and the trust has again reported a net loss, this time ¥82.673 million. The central story today is earnings pressure and the strain that continued losses...

Beijing Energy International Holding stock closed at HK$0.69 after a rough few months, with the share price down almost 30% over 90 days. Yet the latest half year numbers tell a more complicated story. Revenue for H1 2026 came in at ¥3,784m while the company reported a net loss of ¥120m. The market appears to be fixated on another loss and the long run record of earnings pressure. The real question now is whether this latest profit squeeze justifies the existing discount on the shares or...

Gemdale Properties and Investment stock heads into this earnings recap trading at about HK$0.10, after a modest rebound over the past month but with a weak 90 day stretch still hanging over it. The headline is simple and harsh. H1 2026 again brought heavy losses, with basic earnings per share in the red and net income firmly negative, even as revenue stayed in the billions of renminbi. The sentiment reckoning for you as an investor centers on the balance sheet and valuation strain. The share...

Shenwan Hongyuan (H.K.) came into these results with a flat 7 day share price and a muted 30 day slip, yet the latest numbers point to a business quietly grinding out profits. The stock closed at HK$0.965 on 26 August, while the headline from H1 2026 is simple: earnings stayed in the black and the trailing twelve month basic earnings per share reached HK$0.077766, putting the stock on a 12.4x P/E. For a capital markets broker that only recently turned profitable, the focus now is on how...

E-Commodities Holdings stock has been on a quiet tear, with double digit gains over the past month and quarter. Today, however, the real story is not the share price. The headline from this half year result is a sharp earnings punch, with basic earnings per share at HK$0.095 and net income of HK$250.361 million. For a low P/E stock trading around HK$0.775, that profit recovery is what long term holders will care about most. The short term price chart looks strong, but the bigger question now...

West China Cement stock closed at HK$2.03 after a choppy few months that included a 7 day gain and a weaker 90 day stretch. The headline from these H1 2026 numbers is profit compression. Basic earnings per share came in at C¥0.069 on revenue of C¥4,526.9m, with a trailing net margin of 5.8% compared with 9.8% a year earlier. Short term traders may focus on that squeeze. Longer term investors will be weighing it against forecasts for faster earnings and revenue growth, and a share price that...

Beijing Enterprises Urban Resources Group came into these results priced like a forgotten small cap, with the stock at HK$0.405 and only a flat month behind it. The market has treated this as a low‑expectation value story. The headline from H1 2026 is that profitability has held together, with basic earnings per share at CN¥0.0099 and net income of CN¥35.329m, even as revenue printed at CN¥3,132.432m. For a waste services operator that only recently turned profitable on a trailing basis, the...

TVB’s share price has drifted down in recent weeks, yet today’s earnings story is less about the chart and more about a pressure point on the income statement. The headline is a squeeze on profit in the first half of 2026, with revenue of HK$1,257.5m sitting alongside a net loss of HK$73.6m and a basic loss per share of HK$0.16. For a stock trading on an 11.4x P/E and already flagged for weak interest coverage, that mix of thin earnings support and financing strain is what is really driving...

Laekna shares closed at HK$6.26 on Wednesday, capping a choppy three months in which the stock has fallen sharply despite analysts pointing to very large implied upside. The H1 2026 earnings print sharpened that tension. The company is still loss making, yet the headline story this half is how small the loss has become relative to its revenue base. Laekna booked revenue of C¥150.3m in the first half of 2026 and reported a basic loss per share of C¥0.01, alongside a net loss of C¥2.5m. For a...

Long term Treasury yields around 4.73% on the 10 year and 5.27% on the 30 year have pushed bonds back into the spotlight, while the U.S. Treasury’s larger buybacks keep liquidity in focus without the comfort of full scale stimulus. For investors, that mix can reshuffle which stocks look attractive. This article explains the broader environment and then walks through three life and annuity insurers that are exposed to these dynamics. The three insurers covered below are only a starting sample,...

Ascentage Pharma Group International (SEHK:6855) updated investors with its half-year 2026 results, reporting CNY 302.21 million in sales and a net loss of CNY 816.69 million, along with wider basic and diluted loss per share. Ascentage Pharma Group International’s latest half year loss update comes after a period in which the share price has fallen 16.97% over 90 days and 34.62% year to date, contributing to a 60.14% decline in 1 year total shareholder return, despite a positive 3 year total...